Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01631552
What this trial is testing

Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer

Who this might be right for
Gastric AdenocarcinomaEsophageal CancerHepatocellular Carcinoma+13 more
Gilead Sciences 515
Testing effectiveness (Phase 2)UnknownNCT00669747
What this trial is testing

Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)

Who this might be right for
Ductal Carcinoma In Situ
Windy Hill Medical, Inc. 45
Not applicableStudy completedNCT01060085
What this trial is testing

Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging

Who this might be right for
Ductal Carcinoma In SituInvasive Breast Cancer
Dartmouth-Hitchcock Medical Center 51
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Early research (Phase 1)UnknownNCT01462903
What this trial is testing

Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors

Who this might be right for
Nasopharyngeal CarcinomaHepatocellular CarcinomaBreast Carcinoma
Sun Yat-sen University 20
Not applicableActive Not RecruitingNCT03878342
What this trial is testing

Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast

Who this might be right for
DCISBreast CancerLow Risk DCIS+2 more
UNICANCER 295
Early research (Phase 1)Study completedNCT03319459
What this trial is testing

FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors

Who this might be right for
HER2 Positive Gastric CancerColorectal CancerHead and Neck Squamous Cell Carcinoma+8 more
Fate Therapeutics 44
Large-scale testing (Phase 3)Looking for participantsNCT05796973
What this trial is testing

Measuring Oncological Value of Exercise and Statin

Who this might be right for
Prostate CancerBreast CancerKidney Cancer+9 more
Tampere University Hospital 240
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Early research (Phase 1)Study completedNCT00089362
What this trial is testing

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more
National Cancer Institute (NCI) 30
Not applicableStudy completedNCT06234488
What this trial is testing

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

Who this might be right for
Breast CancerBreast NeoplasmsBreast Adenocarcinoma+4 more
Medical College of Wisconsin 125
Testing effectiveness (Phase 2)Study completedNCT02993159
What this trial is testing

Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor Positive
Northwestern University 100
Early research (Phase 1)Looking for participantsNCT05092373
What this trial is testing

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Who this might be right for
Advanced Breast CarcinomaAdvanced Endometrial CarcinomaAdvanced Fallopian Tube Carcinoma+71 more
M.D. Anderson Cancer Center 43
Early research (Phase 1)Study completedNCT00028496
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more
National Cancer Institute (NCI) 48
Large-scale testing (Phase 3)Study completedNCT00757302
What this trial is testing

Intraoperative Gamma Camera for Breast Cancer Surgery

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
University Hospital, Strasbourg, France 110
Testing effectiveness (Phase 2)Study completedNCT02282345
What this trial is testing

Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer

Who this might be right for
Breast AdenocarcinomaDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+2 more
M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT01023477
What this trial is testing

Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)

Who this might be right for
Carcinoma, Intraductal, NoninfiltratingDCISDuctal Carcinoma In Situ
Inova Health Care Services 12
Early research (Phase 1)Ended earlyNCT00689065
What this trial is testing

Safety Study of CALAA-01 to Treat Solid Tumor Cancers

Who this might be right for
CancerSolid Tumor
Calando Pharmaceuticals 24
Very early researchWithdrawnNCT01055678
What this trial is testing

To Evaluate the Characteristics of a Breast Cancer

Who this might be right for
Breast Cancer
Mark Dewhirst
Not applicableStudy completedNCT00897208
What this trial is testing

Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Mayo Clinic 316
Next Page